Icariside II Inhibits Gastric Cancer Progression by Suppressing the Wnt/β-Catenin Signaling Pathway
May 2025
in “
Cytotechnology
”
Studysummary This study observed that Icariside II, an extract from Epimedium brevicornu Maxim, can inhibit the growth of gastric cancer in cell lines and mouse models by promoting apoptosis and suppressing the Wnt/β-catenin signaling pathway, with minimal toxicity to normal gastric cells.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on pmc.ncbi.nlm.nih.gov →